AFP and hepatocellular carcinoma: Current guidelines and consensus for the prevention and control of HCC in China recommend a screening program for serum alpha‐fetoprotein (AFP) along with liver ultrasonography every 6 months in hepatitis B surface antigen (HBsAg)‐positive populations.